Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-25-005924
Filing Date
2025-02-25
Accepted
2025-02-25 21:00:19
Documents
2
Period of Report
2025-02-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1481
2 EXHIBIT 24 ef20044363_ex24.htm EX-24 7319
  Complete submission text file 0001140361-25-005924.txt   10226
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Issuer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 50 BROADWAY 7TH FLOOR LONDON X0 SW1H 0DB
Business Address
Humes Jennifer (Reporting) CIK: 0002058012 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40782 | Film No.: 25665763